The effect of SGLT2is on neurohormonal activation was also analyzed by Chen et al. in a recent meta-analysis of 18 trials with HF patients and SGLT2is; the study showed a significant reduction in NTproBNP by at least 20% (p = 0.02) [25]. This evidence concerns the gene NPPB and hydrops fetalis.